Literature DB >> 14766441

Psychiatric comorbidity and not completing jail-based substance abuse treatment.

Thomas M Brady1, Christopher P Krebs, Glen Laird.   

Abstract

Many jail inmates have a history of mental illness, substance use, and drug-related crime. This article assesses the effect of psychiatric comorbidity on retention in jail-based substance abuse treatment. Secondary data from five jail-based substance abuse treatment programs were studied using descriptive and multivariate analyses. Controlling for age, sex, race, education, and program, the odds of an offender with a history of mental illness being terminated from treatment were nearly three times that of those with no such history. The data suggest that psychiatric comorbidity may be an important correlate of retention in jail-based substance abuse treatment.

Entities:  

Mesh:

Year:  2004        PMID: 14766441     DOI: 10.1080/10550490490265398

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  18 in total

1.  CJDATS Co-Occurring Disorders Screening Instrument for Mental Disorders (CODSI-MD): A Pilot Study.

Authors:  Stanley Sacks; Gerald Melnick; Carrie Coen; Steven Banks; Peter D Friedmann; Christine Grella; Kevin Knight
Journal:  Prison J       Date:  2007-03

2.  An examination of psychiatric comorbidities as a function of gender and substance type within an inpatient substance use treatment program.

Authors:  Kevin W Chen; Annie N Banducci; Leila Guller; Richard J Macatee; Anna Lavelle; Stacey B Daughters; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-04-22       Impact factor: 4.492

3.  Pilot study of treatment for major depression among women prisoners with substance use disorder.

Authors:  Jennifer E Johnson; Caron Zlotnick
Journal:  J Psychiatr Res       Date:  2012-06-12       Impact factor: 4.791

4.  Predictors of engagement in the Alcoholics Anonymous group or to psychotherapy among Brazilian alcoholics : a six-month follow-up study.

Authors:  Mauro Barbosa Terra; Helena Maria Tannhauser Barros; Airton Tetelbom Stein; Ivan Figueira; Luciana Dias Athayde; Luiz Henrique Palermo; Letícia Piccoli Tergolina; Joana Stela Rovani; Dartiu Xavier da Silveira
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-04-01       Impact factor: 5.270

5.  Assessing need for medication-assisted treatment for opiate-dependent prison inmates.

Authors:  Carmen E Albizu-García; José Noel Caraballo; Glorimar Caraballo-Correa; Adriana Hernández-Viver; Luis Román-Badenas
Journal:  Subst Abus       Date:  2012       Impact factor: 3.716

6.  Randomized cost-effectiveness trial of group interpersonal psychotherapy (IPT) for prisoners with major depression.

Authors:  Jennifer E Johnson; Robert L Stout; Ted R Miller; Caron Zlotnick; Louis A Cerbo; Joel T Andrade; Jessica Nargiso; Joseph Bonner; Shannon Wiltsey-Stirman
Journal:  J Consult Clin Psychol       Date:  2019-02-04

7.  “I know if I drink I won’t feel anything”: substance use relapse among depressed women leaving prison.

Authors:  Jennifer E Johnson; Yael Chatav Schonbrun; Jessica E Nargiso; Caroline C Kuo; Ruth T Shefner; Collette A Williams; Caron Zlotnick
Journal:  Int J Prison Health       Date:  2013

8.  Clinical characteristics as a function of referral status among substance users in residential treatment.

Authors:  Anne N Banducci; Jennifer Dahne; Jessica F Magidson; Kevin Chen; Stacey B Daughters; C W Lejuez
Journal:  Addict Behav       Date:  2012-12-24       Impact factor: 3.913

9.  Multimodal assessment of emotional reactivity in borderline personality pathology: the moderating role of posttraumatic stress disorder symptoms.

Authors:  Katherine L Dixon-Gordon; Kim L Gratz; Matthew T Tull
Journal:  Compr Psychiatry       Date:  2013-02-01       Impact factor: 3.735

10.  Social support network characteristics of incarcerated women with co-occurring major depressive and substance use disorders.

Authors:  Jessica E Nargiso; Caroline C Kuo; Caron Zlotnick; Jennifer E Johnson
Journal:  J Psychoactive Drugs       Date:  2014 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.